MESTIT1: A Protein Involved in Cell Signaling and Cancer (G317751)

Target Name: MESTIT1

NCBI ID: G317751

MESTIT1

MESTIT1: A Protein Involved in Cell Signaling and Cancer

MESTIT1 (MEST-IT) is a protein that is expressed in a variety of tissues throughout the body, including the brain, heart, liver, and pancreas. It is a member of the Mest family of proteins, which are known for their role in cell signaling and inflammation.

One of the functions of MESTIT1 is to regulate the activity of the transcription factor, NF-kappa-B, which is a protein that plays a role in the regulation of inflammation and immune responses. MESTIT1 has been shown to interact with NF-kappa-B and to influence the activity of this protein.

In addition to its role in cell signaling and inflammation, MESTIT1 has also been shown to be involved in the regulation of cell growth and the development of cancer. Studies have shown that MESTIT1 promotes the growth of cancer cells and that it is a potential drug target for cancer treatment.

MESTIT1 is also a potential biomarker for the disease, pancreatic cancer. Studies have shown that MESTIT1 is overexpressed in pancreatic cancer and that it is associated with poor prognosis.

MESTIT1 is also a potential drug target for treating other diseases, such as heart disease and liver disease. Studies have shown that MESTIT1 is overexpressed in heart disease and that it is associated with poor outcomes in patients with heart failure. MESTIT1 is also overexpressed in liver disease and is associated with the development of liver cancer.

In conclusion, MESTIT1 is a protein that is involved in a variety of processes in the body, including cell signaling and inflammation. It is a potential drug target for cancer and other diseases. Further research is needed to fully understand the role of MESTIT1 in these processes and to develop effective treatments.

Protein Name: MEST Intronic Transcript 1, Antisense RNA

The "MESTIT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MESTIT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets